https://www.selleckchem.com/pr....oducts/ldn-212854.ht
Unfortunately, during the period without specific oncology treatment, her disease showed an unequivocal progression. Therefore, she started on alectinib with great response, and no liver function alteration recurred. This case suggests that alectinib, even belonging to the same drug class, could be used as an alternative agent when crizotinib is the etiology of liver damage, but more robust evidence has awaited. This case suggests that alectinib, even belonging to the same drug class, could be used as an alternative agent when crizot
Like
Comment
Share
